Harold Bernstein, President, Research and Development, and Chief Medical Officer, on May 14, 2026, sold 15,000 shares in Maze Therapeutics (MAZE) for $393,354.
SEC Filing:
Related Articles
Insider Trading
Universal Insurance Holdings Insider Sold Shares Worth $774,604, According to a Recent SEC Filing
Sean P Downes, Director, Executive Chairman, on May 15, 2026, sold 20,000 shares in Universal Insurance Holdings (UVE) for $774,604. Following the Form 4 filing with the SEC, Downes has control over a total of 1,218,255 common shares of the company, with 1,168,255 shares held directly and 50,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/891166/000128704026000007/xslF345X05/wk-form4_1778882117.xml
$UVE
Insider Trading
Lumentum Holdings Insider Sold Shares Worth $3,066,936, According to a Recent SEC Filing
Pamela Fletcher, Director, on May 14, 2026, sold 3,155 shares in Lumentum Holdings (LITE) for $3,066,936. Following the Form 4 filing with the SEC, Fletcher has control over a total of 7,406 common shares of the company, with 7,406 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1633978/000171103526000001/xslF345X05/form4-05152026_090507.xml
$LITE
Insider Trading
Perimeter Solutions Insider Sold Shares Worth $1,790,813, According to a Recent SEC Filing
Jeffrey Emery, President, Global Fire Safety, on May 13, 2026, sold 53,537 shares in Perimeter Solutions (PRM) for $1,790,813.SEC Filing:https://www.sec.gov/Archives/edgar/data/1880319/000192680926000006/xslF345X05/wk-form4_1778881766.xml
$PRM